| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/13/2013 | CA2858133A1 Uses of immunoconjugates targeting cd138 |
| 06/13/2013 | CA2857982A1 Robust controlled-release peptide formulations |
| 06/13/2013 | CA2857980A1 Dry powder formulation of azole derivative for inhalation |
| 06/13/2013 | CA2857189A1 Topical formulation for administering a compound |
| 06/13/2013 | CA2853138A1 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 06/12/2013 | EP2601974A1 Pharmaceutical preparation for controlling water-soluble drug release |
| 06/12/2013 | EP2601973A1 Dry powder formulation of azole derivative for inhalation |
| 06/12/2013 | EP2601972A2 Non-lithotripsic kidney-stone therapy |
| 06/12/2013 | EP2601971A1 Composition for regeneratng normal tissue from fibrotic tissue |
| 06/12/2013 | EP2601948A1 Preparation for treatment of spinal cord injury |
| 06/12/2013 | EP2601944A1 Transdermal patch and method for augmenting adhesive strength thereof |
| 06/12/2013 | EP2601936A1 Compressed composition |
| 06/12/2013 | EP2601932A1 Lyophilized recombinant VWF formulations |
| 06/12/2013 | EP2601262A1 A multicompartmentalized vesicular structure and a method for forming the same |
| 06/12/2013 | EP2600903A2 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 06/12/2013 | EP2600899A1 Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allergenic diseases |
| 06/12/2013 | EP2600898A1 Anti-mhc antibody anti-viral cytokine fusion protein |
| 06/12/2013 | EP2600886A1 Use of a peptide enhancing the ability of radiation therapy to kill cancer cells |
| 06/12/2013 | EP2600877A2 Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
| 06/12/2013 | EP2600870A2 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream |
| 06/12/2013 | EP2600864A2 Compositions and methods for treating inflammatory diseases |
| 06/12/2013 | EP2600851A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain |
| 06/12/2013 | EP2600850A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain |
| 06/12/2013 | EP2600845A2 Pharmaceutical composition containing a serenoa repens extract |
| 06/12/2013 | EP2600844A2 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof |
| 06/12/2013 | EP2600838A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/12/2013 | EP2600834A1 Collagen-based implants for sustained delivery of drugs |
| 06/12/2013 | EP2600722A2 Use of a n-vinyllactam / vinylimidazol copolymer as dispersing agent |
| 06/12/2013 | CN1942588B Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/12/2013 | CN1525857B Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives |
| 06/12/2013 | CN103154012A Glycodendrimers of polypropyletherimine |
| 06/12/2013 | CN103153927A Fused cyclooctyne compounds and their use in metal-free click reactions |
| 06/12/2013 | CN103153348A Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 06/12/2013 | CN103153345A Amatoxin-conjugates with improved linkers |
| 06/12/2013 | CN103153344A Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 06/12/2013 | CN103153343A Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| 06/12/2013 | CN103153342A Nitric oxide delivery system using thermosensitive synthetic polymers |
| 06/12/2013 | CN103153334A New emd formulation comprising pga |
| 06/12/2013 | CN103153306A Solid dispersion comprising triazole compound |
| 06/12/2013 | CN103153303A Combination therapy using a ruthenium complex |
| 06/12/2013 | CN103153294A Transdermal patch and method for augmenting adhesive strength thereof |
| 06/12/2013 | CN103153290A Antimicrobial formulations that aid in wound healing |
| 06/12/2013 | CN103153288A Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 06/12/2013 | CN103153285A Liposome composition and process for production thereof |
| 06/12/2013 | CN103153282A Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/12/2013 | CN103153281A Liquid pharmaceutical composition for the delivery of active ingredients |
| 06/12/2013 | CN103145977A Preparation method of mPEG2000-DSPE sodium salt |
| 06/12/2013 | CN103145968A Folate-conjugated polyethylene glycol monostearate, and preparation method and application thereof |
| 06/12/2013 | CN103145932A Long-circulating anti-tumor targeting drug carrier and preparation method thereof |
| 06/12/2013 | CN103145851A Recombinant protein PACAP38-NtA, and coding gene and application thereof |
| 06/12/2013 | CN103145847A Anti-CD20 antibody-monomethyl auristatin E conjugate, its preparation method and application |
| 06/12/2013 | CN103145844A A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/12/2013 | CN103145826A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 06/12/2013 | CN103145799A Group of polypeptides having percutaneous and transmembrane penetration promoting effect, and applications thereof |
| 06/12/2013 | CN103143060A Preparation method of three-dimensional porous membrane with ordered hierarchical nano-structure |
| 06/12/2013 | CN103143057A Graphene/bioactive xerogel and its preparation method and use |
| 06/12/2013 | CN103143033A Targeting liver cell carrier and preparation method thereof |
| 06/12/2013 | CN103143031A Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 06/12/2013 | CN103143030A Dynamic polyrotaxane for adjusting and controlling cholinesterase and preparation method thereof |
| 06/12/2013 | CN103143029A Coating composition containing cellulose ether with low substitution degree, and film-coated preparation with concealed unpleasant taste |
| 06/12/2013 | CN103143028A Sulfhydrylated amphipathic chitosan polymer carrier as well as preparation method and application thereof |
| 06/12/2013 | CN103143027A Preparation of hyaluronic-acid-based double-targeting nano-composite medicament and application of double-targeting nano-composite medicament |
| 06/12/2013 | CN103143026A Block copolymer mPEG-PLGA/amorphous calcium silicate hydrate composite nano material as well as preparation method and application thereof |
| 06/12/2013 | CN103143025A Water-soluble enteric coating powder as well as preparation method and use method thereof |
| 06/12/2013 | CN103143024A Implantable kidney-tonifying bone-invigorating traditional Chinese medicine extract-antibiotic-calcium sulfate sustained-release system, and preparation method and application thereof |
| 06/12/2013 | CN103143018A Oral formulations containing metformin and alpha-glycosidase inhibitor, and preparation method thereof |
| 06/12/2013 | CN103143000A Recombinant human interferon alpha2b preparation |
| 06/12/2013 | CN103142997A Medical composition containing antifungal agent and succinate buffer liquid |
| 06/12/2013 | CN103142990A Medicine for treating animal bacterial diseases and preparation method thereof |
| 06/12/2013 | CN103142889A Pellet preparation for normalizing stomach and tonifying spleen |
| 06/12/2013 | CN103142887A Microcapsule preparation for normalizing stomach and tonifying spleen |
| 06/12/2013 | CN103142886A Granule for normalizing stomach and tonifying spleen |
| 06/12/2013 | CN103142798A Guiqi blood-nourishing dispersible tablet used for regulating menstruation and tonifying blood, and preparation method thereof |
| 06/12/2013 | CN103142760A Ginseng Yangyuanbao tablet and preparation method thereof |
| 06/12/2013 | CN103142749A Anti-bacterial and anti-inflammatory cream |
| 06/12/2013 | CN103142724A Veterinary ephedra-almond-gypsum-licorice chewable tablet and preparation process thereof |
| 06/12/2013 | CN103142697A Pharmaceutical composition for relieving muscular soreness and preparation method thereof |
| 06/12/2013 | CN103142681A Flemingia philippinensis total flavonoids and beta-cyclodextrin clathrate compound and preparation method thereof |
| 06/12/2013 | CN103142660A Wood seed tannic acid treatment cream |
| 06/12/2013 | CN103142659A Film coating tablet containing staphylococcus neisseria |
| 06/12/2013 | CN103142649A Preparation method of amylose-coated I3<->-complexed silver-coated iron composite nanoparticles |
| 06/12/2013 | CN103142648A Arsenic compound solution, and alhumin nanoparticles encapsulated with arsenic compound and freeze-drying preparation prepared by same |
| 06/12/2013 | CN103142645A High stability composite guaiacol phenolsulfonic acid oral liquid and preparation method thereof |
| 06/12/2013 | CN103142644A Calcitriol and sodium fluoride suspension granule and preparation method thereof |
| 06/12/2013 | CN103142642A Calcitriol and calcium carbonate suspension granule and preparation method thereof |
| 06/12/2013 | CN103142634A Spirulina phatensis polysaccharide and cynomorium songaricum polysaccharide preparation and manufacture method thereof and application thereof |
| 06/12/2013 | CN103142623A Calcitriol and strontium ranelate suspension granule and preparation method thereof |
| 06/12/2013 | CN103142622A Triamcinolone acetonide and miconazole emulsion type gel |
| 06/12/2013 | CN103142607A Preparation method of tegafur gimeracil oteracil potassium capsule |
| 06/12/2013 | CN103142606A Paracetamol and caffeine enteric tablet and preparation method thereof |
| 06/12/2013 | CN103142583A Levetiracetam-containing pharmaceutical composition and preparation method thereof |
| 06/12/2013 | CN103142565A Novel nimesulide sustained-release pharmaceutical composition and preparation method thereof |
| 06/12/2013 | CN103142562A Sustained-release sticking film for treating oral ulcer |
| 06/12/2013 | CN103142561A Cataplasm basic material and preparation method thereof |
| 06/12/2013 | CN103142560A Montelukast sodium film-like preparation |
| 06/12/2013 | CN103142559A Risperidone film-like preparation |
| 06/12/2013 | CN103142557A Polymannuronate sulfate slow release capsule and preparation method thereof |
| 06/12/2013 | CN103142556A Polysaccharide sulfate sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142555A Alfacalcidol sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142554A Calcitriol controlled-release capsule and preparation method thereof |